Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia. 1986

H Kuśnierczyk, and J Rak, and C Radzikowski

Antitumor activity of four modified on amino sugar moiety derivatives of daunorubicin was compared with activity of two commercial preparations of the parental drug in tests against P 388 leukemia in mice. Tested analogs appeared to be similarly effective as the reference drugs, but two of them, DR-2 and DR-19, were found to be significantly less potent.

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

H Kuśnierczyk, and J Rak, and C Radzikowski
January 1989, Izvestiia Akademii nauk SSSR. Seriia biologicheskaia,
H Kuśnierczyk, and J Rak, and C Radzikowski
June 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kuśnierczyk, and J Rak, and C Radzikowski
February 1982, Chemical & pharmaceutical bulletin,
H Kuśnierczyk, and J Rak, and C Radzikowski
January 1984, Cancer chemotherapy and pharmacology,
H Kuśnierczyk, and J Rak, and C Radzikowski
January 1987, Folia histochemica et cytobiologica,
H Kuśnierczyk, and J Rak, and C Radzikowski
January 2011, Voprosy onkologii,
H Kuśnierczyk, and J Rak, and C Radzikowski
March 1985, Journal of pharmaceutical sciences,
H Kuśnierczyk, and J Rak, and C Radzikowski
January 1988, Archiv fur Geschwulstforschung,
H Kuśnierczyk, and J Rak, and C Radzikowski
January 1986, Experimental pathology,
H Kuśnierczyk, and J Rak, and C Radzikowski
January 1981, Cancer treatment reports,
Copied contents to your clipboard!